Neoangiogenesis in laryngeal carcinoma: Angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival

Histopathology

Volumn 57, Issue 4, 2010, Pages 535-543

  Marioni, Gino ^a   Marino, Filippo ^a   Blandamura, Stella ^a   D'Alessandro, Emiliano ^a   Giacomelli, Luciano ^a   Guzzardo, Vincenza ^a   Lionello, Marco ^a   De Filippis, Cosimo ^a   Staffieri, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angiogenesis; Angiogenin; CD105; Laryngeal carcinoma; Prognosis; Targeted therapy

Indexed keywords

ANGIOGENIN; ENDOGLIN;

AGED; ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; ENDOTHELIUM CELL; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; RIBONUCLEASE, PANCREATIC; TUMOR MARKERS, BIOLOGICAL;

EID: 78650508750     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03664.x     Document Type: Article

References (32)

1. Fett JW, Strydom DJ, Lobb RR et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24; 5480-5486.
2. Gao X, Xu Z. Mechanisms of action of angiogenin. Acta Biochim. Biophys. Sin. 2008; 40; 619-624.
3. Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, Cheng L. Elevated expression of angiogenin in prostate cancer and its precursors. Clin. Cancer Res. 2005; 11; 8358-8363.
4. Yoshioka N, Wang L, Kishimoto K, Tsuji T, Hu GF. A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc. Natl. Acad. Sci. USA 2006; 103; 14519-14524.
5. Dickson KA, Kang DK, Kwon YS et al. Ribonuclease inhibitor regulates neovascularization by human angiogenin. Biochemistry 2009; 48; 3804-3806.
6. Tello-Montoliu A, Patel JV, Lip GYH. Angiogenin: a review of the pathophysiology and potential clinical applications. J. Thromb. Haemost. 2006; 4; 1864-1876.
7. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003; 22; 6557-6563.
8. Tanaka F, Ishikawa S, Yanagihara K et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res. 2002; 62; 7124-7129.
9. Schimming R, Marmè D. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck 2002; 24; 151-156.
10. Schimming R, Reusch P, Kuschnierz J, Schmelzeisen R. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance? J. Craniomaxillofac. Surg. 2004; 32; 176-181.
11. Nagatsuka H, Hibi K, Gunduz M et al. Various immunostaining patterns of CD31, CD34 and endoglin and their relationship with lymph node metastasis in oral squamous cell carcinomas. J. Oral Pathol. Med. 2005; 34; 70-76.
12. Marioni G, Marino F, Giacomelli L et al. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma. Acta Otolaryngol. 2006; 126; 633-639.
13. Chien CY, Su CY, Hwang CF, Chuang HC, Chen CM, Huang CC. High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J. Surg. Oncol. 2006; 94; 413-417.
14. Chuang HC, Su CY, Huang HY, Chien CY, Chen CM, Huang CC. High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope 2006; 116; 1175-1179.
15. Chien CY, Su CY, Chuang HC et al. Clinical significance of osteopontin expression in T1 and T2 tongue cancers. Head Neck 2008; 30; 776-781.
16. Chien CY, Su CY, Hwang CF et al. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx. Head Neck 2006; 28; 441-446.
17. Martone T, Rosso P, Albera R et al. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol. 2005; 41; 147-155.
18. Kyzas PA, Agnantis NJ, Stefanou D. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Virchows Arch. 2006; 448; 768-775.
19. Marioni G, Ottaviano G, Giacomelli L et al. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. Eur. J. Surg. Oncol. 2006; 32; 1149-1153.
20. Marioni G, Giacomelli L, D'Alessandro E et al. Laryngeal carcinoma recurrence rate and disease free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/KDR) expression. Anticancer Res. 2008; 28; 551-558.
21. Zvrko E, Mikic A, Vuckovic L. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 2009; 266; 1971-1976.
22. Chen Y, Zhang S, Chen YP, Lin JY. Increased expression of angiogenin in gastric carcinoma in correlation with tumor angiogenesis and proliferation. World J. Gastroenterol. 2006; 12; 5135-5139.
23. Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat. Rev. 2006; 32; 504-515.
24. Greene FL, Page DL, Fleming ID et al. eds. AJCC cancer staging manual, 6th edn. New York, NY: Springer, 2002.
25. Cheng J, Slavin RE, Gallagher JA et al. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases. J. Hepatobiliary Pancreat. Surg. 2004; 11; 164-170.
26. Dales JP, Garcia S, Carpentier S et al. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n = 905). Br. J. Cancer 2004; 90; 1216-1221.
27. Homer JJ, Greenman J, Stafford ND. Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcinoma. Clin. Otolaryngol. Allied Sci. 2000; 25; 570-576.
28. Homer JJ, Greenman J, Stafford ND. Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma. Clin. Otolaryngol. Allied Sci. 2002; 27; 32-37.
29. Hisai H, Kato J, Kobune M et al. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin. Cancer Res. 2003; 9; 4852-4859.
30. Marioni G, D'Alessandro E, Giacomelli L et al. Maspin nuclear localization is related to reduced density of tumour-associated microvessels in laryngeal carcinoma. Anticancer Res. 2006; 26; 4927-4932.
31. Thorpe PE. Vascular targeting agents as cancer therapeutics. Clin. Cancer Res. 2004; 10; 415-427.
32. Fonsatti E, Maio M. Highlights on endoglin (CD105): from basic findings towards clinical application in human cancer. J. Transl. Med. 2004; 2; 18.